PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 14, 2025Hypertension Research4 citationsOpen Access

Lack of validated blood pressure devices for use in pregnancy available from Australian pharmacies

KSKaylee SlaterHSHollie SpeerNCNiamh Chapman

Key Result

Only 4 of 54 (7%) home blood pressure devices available from Australian pharmacies were validated for use in pregnancy, and these were more expensive than non-validated devices.

Study Design

Type

Cross-Sectional (n=54)

Structured PICO

P
Population
54 automatic blood pressure devices available from 18 Australian pharmacies
O
Outcome
Availability of automatic blood pressure devices validated for use in pregnancy

There is a significant lack of validated and affordable automatic blood pressure devices for pregnant women in Australian pharmacies, highlighting a need for better availability and consumer education.

Limitations

  • Data collection was restricted to Australian pharmacies with physical and online stores.
  • Did not capture independently owned community pharmacies operating in rural and remote communities that may not have online stores.
  • Did not assess global availability or e-commerce stores such as Amazon.

Abstract

Blood pressure monitoring is a critical aspect of prenatal care, as hypertension during pregnancy can lead to serious complications such as preeclampsia, eclampsia, and other hypertensive disorders. Automatic blood pressure devices are widely used for home monitoring due to their convenience and ease of use. The use of validated automated blood pressure monitors is recommended by the International Society of Hypertension for home blood pressure measurements, and automatic devices require accuracy validation among people who are pregnant before they are recommended for use in pregnancy. This study evaluated availability of such devices from 18 Australian pharmacies. Only four devices (4/54, 7%) were validated for pregnancy and were more expensive than devices validated for the general population (14/54, 26%) and non-validated devices (40/54, 74%). Additionally, limited labelling and information was available to assist consumers to make informed purchasing decisions about home blood pressure devices for use in pregnancy. Increased availability, clear labelling and consumer education could help ensure use of appropriate blood pressure devices in pregnancy. Automatic blood pressure devices require additional accuracy validation for use in pregnancy. We found only four devices (4/54, 7%) were validated for pregnancy, which were more expensive than non-validated devices. Increased education could help ensure use of appropriate blood pressure devices in pregnancy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Slater et al. (2025) conducted a cross-sectional in Hypertension in pregnancy (n=54). Home blood pressure devices was evaluated on Proportion of devices validated for use in pregnancy. Only 4 of 54 (7%) home blood pressure devices available from Australian pharmacies were validated for use in pregnancy, and these were more expensive than non-validated devices.

synapsesocial.com/papers/6a0c6efa106bfae851886c84https://doi.org/10.1038/s41440-025-02304-x
Ask AI
Helpful
Bookmark
Share
View Full Paper